CytomX Therapeutics, Inc. (6C1)
Market Open
23 Oct, 07:57 PM
XSTU 
€
2. 07
-0.09
-4.2996%
€
- Market Cap
- P/E Ratio
- Div Yield
1,000 Volume
-0.06 Eps
€ 2.16
Previous Close Want to track 6C1 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
6C1 Earnings Reports FAQ
What is the earnings per share (EPS) for 6C1?
The current EPS is -0.06.
What is the company's earnings growth rate?
CytomX Therapeutics, Inc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
CytomX Therapeutics, Inc has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for CytomX Therapeutics, Inc are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for 6C1 at this time, as CytomX Therapeutics, Inc has no recent EPS data to calculate it.
2026 © Marketlog. All Rights Reserved.
